Improved kidney function: Recent developments in the management of T2D have identified the use of GLP-1s to reduce the progression of kidney disease in individuals with diabetes
Lipid panels are also relevant, as GLP-1-based therapies may modestly improve cardiovascular risk factors
SGLT2 inhibitors could block the reabsorption of glucose in the kidneys, leading to increased glucose excretion and improved glycemic control in type 2 diabetes
Dulaglutide (Trulicity) : If you miss a dose and remember within three days , administer the missed dose
If you see any cloudiness, discoloration, or particulates in the water, do not use it
Studies have found that glutathione production decreases as people age, especially when women go through menopause